IVF/ICSI Cycle Outcomes Related to Estradiol Drop After GnRH Antagonist

A 15.7 KB document on figshare by Lara Janssens, last updated March 18, 2026, presents data from a study analyzing the impact of a drop in serum estradiol levels after GnRH antagonist administration on clinical outcomes in IVF/ICSI cycles. The results link estradiol drop to lower ongoing pregnancy, live birth, and cumulative live birth rates. The findings suggest estradiol monitoring could help identify cycles with a higher risk of less favorable outcomes.

Use Cases

• Modeling the relationship between estradiol level changes and cumulative live birth rates based on the study's findings.
• Investigating the association between gonadotropins with LH activity and the frequency of estradiol drop as described.
• Analyzing the impact of serum LH decrease after GnRH antagonist administration on ovulation trigger day hormone levels.

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• The study focuses on a specific clinical phenomenon (estradiol drop) with clear outcome measures (pregnancy and live birth rates).
• Platform tags provide clear domain classification.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• The dataset is very small at 15.7 KB, indicating limited scope.
• Data is contained within a DOCX file, which may require extraction for analysis.

Provenance

Source

figshare, authored by Lara Janssens.

Collection Method

Likely contains data from a clinical study analyzing IVF/ICSI cycles.

Freshness

Last updated 2026-03-18 05:34:50.